BTAI BioXcel Therapeutics, Inc. - Common Stock
$0.84
价格 · 八月 19, 2026
截至...的财报数据 八月 13, 2026
52周区间
$1–$6
2% of range
分析师评级
BUY
11 analysts
目标价
$14
+1577% upside
P/E (TTM)
-0.2
ROE
68.8%
净利润率
-10887.4%
BTAI 股票快照 价格、市值、P/E、EPS、ROE、负债/权益、52周范围
价格
$0.83
市值
$23M
P/E (TTM)
-0.2
每股收益 (TTM)
$-5.73
营收 (TTM)
$642.0K
股息收益率
—
ROE
68.8%
负债/权益
-1.1
52周区间
$1 – $6
BTAI 股价图表 包含技术指标的日 OHLCV — 平移、缩放和自定义您的视图
Configure
10年表现 收入、净利润、利润率和每股收益趋势
营收与净利润
$642.0K
2022-12-31
→
2025-12-31
EPS
$-5.73
2020-12-31
→
2025-12-31
自由现金流
$-58M
2018-12-31
→
2025-12-31
利润率
-10887.4%
估值 P/E、P/S、P/B、EV/EBITDA 比率 — 该股票是昂贵还是便宜？
指标
5年趋势
BTAI
同行中位数
P/E (TTM)
-0.2
0.8
P/S (TTM) (市销率 (TTM))
35.2
6.2
P/B (市净率)
-0.2
3.0
EV / EBITDA (企业价值 / EBITDA)
-2.1
—
Price / FCF (股价/自由现金流)
-0.4
—
盈利能力 毛利率、营业利润率和净利率；股本回报率 (ROE)、资产回报率 (ROA)、投入资本回报率 (ROIC)
指标
5年趋势
BTAI
同行中位数
Operating Margin (营业利润率)
-7860.0%
—
Net Profit Margin (净利润率)
-10887.4%
-1056.6%
ROA
-167.9%
-118.6%
ROE
68.8%
-139.5%
财务健康 债务、流动性、偿付能力 — 资产负债表强度
指标
5年趋势
BTAI
同行中位数
Debt / Equity (负债/股东权益比率)
-1.1
—
Current Ratio (流动比率)
0.8
2.1
Quick Ratio (速动比率)
0.5
—
成长 营收、每股收益 (EPS) 和净利润增长：同比、3年复合年增长率 (CAGR)、5年复合年增长率 (CAGR)
指标
5年趋势
BTAI
同行中位数
Revenue YoY (营收同比增长)
-71.7%
—
Revenue CAGR 3Y (营收3年复合年增长率)
19.6%
—
资本效率 资产周转率、库存周转率、应收账款周转率
指标
5年趋势
BTAI
同行中位数
BTAI 分析师共识 看涨和看跌分析师观点、12个月价格目标、上涨空间
买入
11 位分析师
- 强烈买入 2 18.2%
- 买入 7 63.6%
- 持有 1 9.1%
- 卖出 1 9.1%
- 强烈卖出 0 0.0%
12个月价格目标
4 位分析师 · 2026-08-14
中位数
$8.50
平均值
$14.00
← 低于所有目标
$0.83
最低
$1.00
最高
$38.00
中位数目标
$8.50
+918.0%
平均目标
$14.00
+1576.6%
收益历史 每股收益实际值 vs 预估值，惊喜%，达标率，下次财报日期
平均惊喜
1.2%
| 期间 | EPS Actual | EPS 预期 | 惊喜 |
|---|---|---|---|
| 2026年3月31日 | $-0.54 | $-0.84 | 0.30% |
| 2025年12月31日 | $-0.58 | $-0.77 | 0.18% |
| 2025年9月30日 | $-2.18 | $-1.20 | -0.98% |
| 2025年6月30日 | $-2.45 | $-1.89 | -0.56% |
| 2025年3月31日 | $-1.50 | $-6.79 | 5.3% |
| 2024年12月31日 | $-3.57 | $-6.55 | 3.0% |
同行比较（GICS 子行业） 关键指标与行业同行对比
| 股票代码 | 市值 | P/E | 营收同比增长 | 净利润率 | ROE | 毛利率 |
|---|---|---|---|---|---|---|
| BTAI | $36M | -0.3 | -71.7% | -10887.4% | 68.8% | — |
| ELUT | — | 0.8 | -15.0% | 434.2% | -753.4% | 53.7% |
| NXTC | $50M | -0.7 | — | — | -172.9% | — |
| QNCX | $187M | -2.0 | — | — | 700.5% | — |
| BYSI | — | — | — | — | 3.1% | — |
| LTRN | — | -1.9 | — | — | — | — |
完整基本面 所有年度指标 — 损益表、资产负债表、现金流量表
损益表 16
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | $642.0K | $2M | $1M | $375.0K | |
| Cost of Revenue | $164.0K | $2M | $1M | $20.0K | |
| R&D Expense | $30M | $30M | $84M | $91M | |
| SG&A Expense | $20M | $34M | $83M | $69M | |
| Operating Expenses | $51M | $70M | $173M | $160M | |
| Operating Income | $-50M | $-67M | $-172M | $-160M | |
| Interest Expense | · | · | $13M | $8M | |
| Interest Income | $1M | $3M | $6M | $3M | |
| Other Non-op | $-4M | $20M | $394.0K | $-427.0K | |
| Income Tax | $0 | $0 | $0 | · | |
| Net Income | $-70M | $-60M | $-179M | $-166M | |
| EPS (Basic) | $-5.73 | $-23.51 | $-98.33 | $-5.92 | |
| EPS (Diluted) | $-5.73 | $-23.51 | $-98.33 | $-5.92 | |
| Shares (Basic) | 12,208,000 | 2,535,000 | 1,821,000 | 28,015,000 | |
| Shares (Diluted) | 12,208,000 | 2,535,000 | 1,821,000 | 28,015,000 | |
| EBITDA | $-50M | $-67M | $-172M | · |
资产负债表 24
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Cash & Equivalents | $28M | $30M | $65M | $194M | |
| Receivables | $233.0K | $131.0K | $71.0K | $248.0K | |
| Inventory | $722.0K | $679.0K | $2M | $2M | |
| Prepaid Expense | $4M | $5M | $3M | $3M | |
| Other Current Assets | $11M | $1M | $2M | $4M | |
| Current Assets | $45M | $37M | $72M | $203M | |
| PP&E (Net) | $175.0K | $475.0K | $784.0K | $1M | |
| PP&E (Gross) | $2M | $2M | $2M | $2M | |
| Accum. Depreciation | $2M | $2M | $1M | $885.0K | |
| Other Non-current Assets | $0 | $87.0K | $87.0K | $925.0K | |
| Total Assets | $45M | $38M | $74M | $206M | |
| Accounts Payable | $15M | $16M | $14M | $10M | |
| Accrued Liabilities | $4M | $6M | $12M | $19M | |
| Current Liabilities | $54M | $22M | $27M | $33M | |
| Capital Leases | $0 | $65.0K | $440.0K | $786.0K | |
| Total Liabilities | $140M | $131M | $130M | $129M | |
| Long-term Debt | $110M | $103M | · | · | |
| Total Debt | $110M | $103M | $101M | · | |
| Common Stock | $76.0K | $49.0K | $30.0K | $28.0K | |
| Paid-in Capital | $625M | $557M | $534M | $488M | |
| Retained Earnings | $-720M | $-650M | $-591M | $-412M | |
| Stockholders' Equity | $-95M | $-93M | $-57M | $77M | |
| Liabilities + Equity | $45M | $38M | $74M | $206M | |
| Shares Outstanding | 22,328,000 | 3,102,000 | 1,871,000 | 1,759,000 |
现金流 12
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Stock-based Comp | $3M | $6M | $19M | $17M | |
| Restructuring | $194.0K | $2M | $4M | · | |
| Operating Cash Flow | $-58M | $-72M | $-155M | $-135M | |
| CapEx | $0 | $0 | $20.0K | $139.0K | |
| Investing Cash Flow | $0 | $0 | $-20.0K | $-139.0K | |
| Debt Issued | · | · | · | $99M | |
| Net Debt Issued | $0 | $-2M | · | · | |
| Stock Issued | · | · | $27M | · | |
| Net Stock Activity | · | · | $27M | · | |
| Financing Cash Flow | $57M | $37M | $27M | $96M | |
| Net Change in Cash | $-1M | $-35M | $-129M | $-39M | |
| Free Cash Flow | $-58M | · | $-155M | · |
盈利能力 5
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Operating Margin | -7860.0% | -2967.6% | -12448.0% | · | |
| Net Margin | -10887.4% | -2630.1% | -12974.9% | · | |
| EBITDA Margin | -7860.0% | -2967.6% | -12448.0% | · | |
| ROA | -167.9% | -106.4% | -128.1% | · | |
| ROE | 68.8% | 66.7% | 368.7% | · |
流动性与偿付能力 5
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Current Ratio | 0.8 | 1.7 | 2.6 | · | |
| Quick Ratio | 0.5 | 1.3 | 2.4 | · | |
| Debt / Equity | -1.1 | -1.1 | -1.8 | · | |
| LT Debt / Equity | -0.9 | -1.1 | -1.8 | · | |
| Interest Coverage | · | · | -12.9 | · |
效率 3
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | 0.0 | · | |
| Inventory Turnover | 0.2 | 1.6 | 0.6 | · | |
| Receivables Turnover | 3.5 | 22.4 | 8.7 | · |
增长率 2
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue YoY | -71.7% | 64.2% | 268.0% | · | |
| Revenue CAGR 3Y | 19.6% | · | · | · |
估值 (TTM) 14
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue TTM | $642.0K | $2M | $1M | $375.0K | |
| Net Income TTM | $-70M | $-60M | $-179M | $-166M | |
| Market Cap | $36M | $19M | $1.41B | · | |
| Enterprise Value | $117M | $91M | $1.45B | · | |
| P/E | -0.3 | -0.3 | -0.5 | -58.1 | |
| P/S | 55.6 | 8.2 | 1023.7 | · | |
| P/B | -0.4 | -0.2 | -25.0 | · | |
| P / Tangible Book | · | · | · | 126.0 | |
| P / Cash Flow | -0.6 | -0.3 | -9.1 | · | |
| P / FCF | -0.6 | · | -9.1 | · | |
| EV / EBITDA | -2.3 | -1.4 | -8.4 | · | |
| EV / FCF | -2.0 | · | -9.3 | · | |
| EV / Revenue | 182.1 | 40.3 | 1049.3 | · | |
| Earnings Yield | -358.1% | -392.9% | -208.3% | -1.7% |
损益表 15
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $182.0K | $206.0K | $256.0K | $98.0K | $120.0K | $168.0K | $366.0K | $214.0K | $1M | $582.0K | $376.0K | $341.0K | $457.0K | $206.0K | $238.0K | $137.0K | |
| Cost of Revenue | $22.0K | $283.0K | $32.0K | $11.0K | $107.0K | $14.0K | $831.0K | $1M | $62.0K | $80.0K | $713.0K | $512.0K | $26.0K | $9.0K | $9.0K | $11.0K | |
| R&D Expense | $3M | $3M | $7M | $9M | $10M | $5M | $6M | $5M | $8M | $11M | $10M | $20M | $27M | $28M | $33M | $22M | |
| SG&A Expense | $7M | $7M | $4M | $5M | $6M | $6M | $4M | $8M | $9M | $13M | $10M | $24M | $26M | $24M | $20M | $17M | |
| Operating Expenses | $10M | $10M | $11M | $14M | $16M | $10M | $11M | $16M | $18M | $25M | $20M | $49M | $53M | $51M | $53M | $39M | |
| Operating Income | $-10M | $-10M | $-10M | $-14M | $-16M | $-10M | $-10M | $-15M | $-17M | $-24M | $-20M | $-48M | $-52M | $-51M | $-53M | $-39M | |
| Interest Expense | · | · | · | · | · | · | · | · | · | $4M | · | $3M | $3M | $3M | $3M | $4M | |
| Interest Income | $131.0K | $211.0K | $321.0K | $236.0K | $230.0K | $279.0K | $368.0K | $616.0K | $671.0K | $947.0K | $945.0K | $1M | $2M | $2M | $1M | $823.0K | |
| Other Non-op | $-394.0K | $2M | $2M | $-13M | $657.0K | $7M | $3M | $5M | $12M | $32.0K | $108.0K | $-5.0K | $537.0K | $-246.0K | $-480.0K | $62.0K | |
| Net Income | $-15M | $-13M | $-13M | $-31M | $-19M | $-7M | $-11M | $-14M | $-8M | $-27M | $-22M | $-50M | $-54M | $-53M | $-55M | $-42M | |
| EPS (Basic) | $-0.49 | $-0.54 | $0.40 | $-2.18 | $-2.45 | $-1.50 | $-1.17 | $-5.15 | $-3.30 | $-13.89 | $-92.94 | $-1.72 | $-1.83 | $-1.84 | $-1.96 | $-1.49 | |
| EPS (Diluted) | $-0.49 | $-0.54 | $0.40 | $-2.18 | $-2.45 | $-1.50 | $-1.17 | $-5.15 | $-3.30 | $-13.89 | $-92.94 | $-1.72 | $-1.83 | $-1.84 | $-1.96 | $-1.49 | |
| Shares (Basic) | 30,300,000 | 23,571,000 | -14,665,000 | 14,196,000 | 7,843,000 | 4,834,000 | -4,559,000 | 2,649,000 | 2,516,000 | 1,929,000 | -85,250,000 | 29,268,000 | 29,187,000 | 28,616,000 | -55,976,000 | 28,022,000 | |
| Shares (Diluted) | 30,300,000 | 23,571,000 | -14,665,000 | 14,196,000 | 7,843,000 | 4,834,000 | -4,559,000 | 2,649,000 | 2,516,000 | 1,929,000 | -85,250,000 | 29,268,000 | 29,187,000 | 28,616,000 | -28,023,980 | 28,022,000 | |
| EBITDA | $-10M | · | · | $-14M | $-16M | $-10M | · | $-15M | $-17M | $-24M | · | $-48M | $-52M | $-51M | · | $-39M |
资产负债表 24
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $13M | $17M | $28M | $36M | $17M | $31M | $30M | $40M | $56M | $74M | $65M | $90M | $128M | $166M | $194M | $232M | |
| Receivables | $82.0K | $216.0K | $233.0K | $0 | $17.0K | · | $131.0K | $3.0K | $812.0K | $378.0K | $71.0K | $735.0K | $431.0K | $283.0K | $248.0K | · | |
| Inventory | $483.0K | $500.0K | $722.0K | $459.0K | $506.0K | $642.0K | $679.0K | $2M | $3M | $2M | $2M | $2M | $2M | $2M | $2M | $1M | |
| Prepaid Expense | $3M | $4M | $4M | $6M | $5M | $5M | $5M | $4M | $3M | $2M | $3M | $4M | $4M | $5M | $3M | $6M | |
| Other Current Assets | $11M | $12M | $11M | $934.0K | $995.0K | $1M | $1M | $1M | $2M | $2M | $2M | $2M | $5M | $5M | $4M | $2M | |
| Current Assets | $29M | $34M | $45M | $44M | $25M | $38M | $37M | $48M | $64M | $81M | $72M | $99M | $138M | $177M | $203M | $242M | |
| PP&E (Net) | $99.0K | $117.0K | $175.0K | $249.0K | $324.0K | $399.0K | $475.0K | $552.0K | $629.0K | $706.0K | $784.0K | $862.0K | $941.0K | $1M | $1M | $1M | |
| PP&E (Gross) | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | |
| Accum. Depreciation | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $1M | $1M | $1M | $1M | $1M | $1M | $965.0K | $885.0K | $848.0K | |
| Other Non-current Assets | · | · | $0 | $0 | · | $87.0K | $87.0K | $87.0K | $87.0K | $87.0K | $87.0K | $87.0K | $87.0K | $925.0K | $925.0K | $925.0K | |
| Total Assets | $29M | $34M | $45M | $45M | $26M | $39M | $38M | $49M | $65M | $82M | $74M | $100M | $140M | $180M | $206M | $245M | |
| Accounts Payable | $19M | $16M | $15M | $16M | $17M | $15M | $16M | $15M | $13M | $17M | $14M | $11M | $11M | $8M | $10M | $6M | |
| Accrued Liabilities | $4M | $6M | $4M | $4M | $5M | $4M | $6M | $10M | $13M | $14M | $12M | $27M | $19M | $17M | $19M | $14M | |
| Current Liabilities | $137M | $55M | $54M | $38M | $33M | $26M | $22M | $26M | $27M | $31M | $27M | $39M | $35M | $29M | $33M | $23M | |
| Capital Leases | · | · | $0 | $0 | · | · | $65.0K | $161.0K | $256.0K | $350.0K | $440.0K | $529.0K | $617.0K | $703.0K | $786.0K | $868.0K | |
| Total Liabilities | $144M | $140M | $140M | $134M | $133M | $129M | $131M | $135M | $140M | $155M | $130M | $141M | $134M | $127M | $129M | $118M | |
| Long-term Debt | $104M | $100M | $110M | $109M | $109M | $106M | $103M | · | · | · | · | · | · | · | · | · | |
| Total Debt | $104M | · | · | $109M | $109M | $106M | · | $104M | $103M | $102M | · | $99M | $97M | $95M | · | $92M | |
| Common Stock | $31.0K | $27.0K | $76.0K | $73.0K | $60.0K | $59.0K | $49.0K | $42.0K | $40.0K | $34.0K | $30.0K | $29.0K | $29.0K | $29.0K | $28.0K | $28.0K | |
| Paid-in Capital | $632M | $627M | $625M | $619M | $569M | $567M | $557M | $554M | $551M | $545M | $534M | $528M | $524M | $517M | $488M | $484M | |
| Retained Earnings | $-747M | $-733M | $-720M | $-708M | $-677M | $-657M | $-650M | $-639M | $-626M | $-617M | $-591M | $-568M | $-518M | $-464M | $-412M | $-357M | |
| Stockholders' Equity | $-115M | $-106M | $-95M | $-89M | $-108M | $-90M | $-93M | $-86M | $-74M | $-72M | $-57M | $-41M | $6M | $53M | $77M | $127M | |
| Liabilities + Equity | $29M | $34M | $45M | $45M | $26M | $39M | $38M | $49M | $65M | $82M | $74M | $100M | $140M | $180M | $206M | $245M | |
| Shares Outstanding | 31,305,000 | 27,075,000 | 22,328,000 | 19,996,000 | 6,620,000 | 5,468,000 | 3,102,000 | 42,462,000 | 40,383,000 | 33,632,000 | 1,871,000 | 29,273,000 | 29,267,000 | 29,100,000 | 28,147,000 | 28,023,000 |
现金流 10
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $358.0K | $435.0K | $450.0K | $581.0K | $2M | $180.0K | $-199.0K | $2M | $1M | $3M | $4M | $4M | $6M | $5M | $5M | $4M | |
| Restructuring | · | $0 | $0 | $194.0K | $0 | $0 | $32.0K | $2M | $856.0K | · | $0 | $4M | · | · | · | · | |
| Operating Cash Flow | $-6M | $-12M | $-14M | $-19M | $-13M | $-12M | $-15M | $-16M | $-23M | $-18M | $-27M | $-38M | $-38M | $-52M | $-39M | $-31M | |
| CapEx | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | · | · | $0 | $0 | · | · | $0 | $0 | |
| Investing Cash Flow | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | · | · | $0 | $0 | · | · | $0 | $0 | |
| Debt Issued | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $0 | $30M | |
| Stock Issued | · | · | · | · | · | · | · | · | · | · | · | $0 | $0 | $25M | · | · | |
| Net Stock Activity | · | · | · | · | · | · | · | · | · | · | · | · | · | $25M | · | · | |
| Financing Cash Flow | $3M | $232.0K | $6M | $38M | $137.0K | $13M | $4M | $454.0K | $5M | $27M | $2M | $0 | $250.0K | $24M | $50.0K | $30M | |
| Net Change in Cash | $-3M | $-12M | $-9M | $19M | $-12M | $1M | $-11M | $-16M | $-18M | $9M | $-25M | $-38M | $-38M | $-28M | $-39M | $-1M |
盈利能力 5
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -5600.6% | · | · | -14518.4% | -13210.0% | -6011.3% | · | -7146.3% | -1566.7% | -4151.7% | · | -14163.3% | -11469.1% | -24853.4% | · | -28459.8% | |
| Net Margin | -8084.1% | · | · | -31541.8% | -15989.2% | -4317.9% | · | -6378.5% | -751.7% | -4603.3% | · | -14805.3% | -11710.1% | -25629.1% | · | -30514.6% | |
| EBITDA Margin | -5600.6% | · | · | -14518.4% | -13210.0% | -6011.3% | · | -7146.3% | -1566.7% | -4151.7% | · | -14163.3% | -11469.1% | -24853.4% | · | -28459.8% | |
| ROA | -53.9% | · | · | -66.0% | -42.1% | -12.0% | · | -18.3% | -8.1% | -20.4% | · | -29.2% | -27.6% | -27.0% | · | -16.5% | |
| ROE | 13.2% | · | · | 35.4% | 21.1% | 8.9% | · | 21.6% | 24.2% | 276.8% | · | -116.9% | -62.9% | -42.8% | · | -22.4% |
流动性与偿付能力 5
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 0.2 | · | · | 1.2 | 0.8 | 1.5 | · | 1.9 | 2.4 | 2.6 | · | 2.5 | 4.0 | 6.2 | · | 10.3 | |
| Quick Ratio | 0.1 | · | · | 1.0 | 0.5 | 1.2 | · | 1.6 | 2.1 | 2.4 | · | 2.3 | 3.7 | 5.8 | · | 9.9 | |
| Debt / Equity | -0.9 | · | · | -1.2 | -1.0 | -1.2 | · | -1.2 | -1.4 | -1.4 | · | -2.4 | 16.5 | 1.8 | · | 0.7 | |
| LT Debt / Equity | 0.0 | · | · | -1.0 | -0.9 | -1.1 | · | -1.2 | -1.4 | -1.4 | · | -2.4 | 16.5 | 1.8 | · | 0.7 | |
| Interest Coverage | · | · | · | · | · | · | · | · | · | -6.7 | · | -14.9 | -16.1 | -15.2 | · | -10.5 |
效率 3
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | · | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | |
| Inventory Turnover | 0.0 | · | · | 0.0 | 0.1 | 0.0 | · | 0.7 | 0.0 | 0.0 | · | 0.3 | 0.0 | 0.0 | · | 0.0 | |
| Receivables Turnover | 3.7 | · | · | 65.3 | 0.3 | · | · | 0.6 | 1.8 | 1.8 | · | 0.9 | 2.1 | 1.5 | · | · |
估值 (TTM) 12
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $606.0K | $592.0K | · | $600.0K | $2M | $2M | · | $2M | $2M | $2M | · | $1M | · | · | · | · | |
| Net Income TTM | $-78M | $-70M | · | $-71M | $-48M | $-56M | · | $-99M | $-139M | $-184M | · | $-199M | $-186M | $-164M | · | $-138M | |
| Market Cap | $44M | · | · | $51M | $12M | $11M | · | $414M | $827M | $1.52B | · | $1.18B | $3.12B | $8.69B | · | $5.30B | |
| Enterprise Value | $136M | · | · | $124M | $103M | $86M | · | $478M | $874M | $1.54B | · | $1.19B | $3.09B | $8.62B | · | $5.16B | |
| P/E | -0.2 | -0.2 | · | -0.2 | -0.1 | -0.1 | · | -0.4 | -1.0 | -2.3 | · | -5.9 | -16.4 | -51.5 | · | -38.4 | |
| P/S | 72.8 | · | · | 85.3 | 7.5 | 5.4 | · | 184.9 | 332.9 | 956.8 | · | 1038.5 | · | · | · | · | |
| P/B | -0.4 | · | · | -0.6 | -0.1 | -0.1 | · | -4.8 | -11.1 | -21.0 | · | -29.2 | 531.8 | 163.9 | · | 41.7 | |
| P / Tangible Book | · | · | · | · | · | · | · | · | · | · | · | · | 531.8 | 163.9 | · | 41.7 | |
| P / Cash Flow | · | · | · | · | · | -0.9 | · | · | · | -85.7 | · | · | · | -166.0 | · | · | |
| EV / EBITDA | -13.3 | · | · | -8.7 | -6.5 | -8.5 | · | -31.3 | -50.5 | -63.9 | · | -24.7 | -58.9 | -168.3 | · | -132.3 | |
| EV / Revenue | 224.0 | · | · | 206.9 | 64.3 | 41.4 | · | 213.5 | 351.8 | 974.1 | · | 1046.5 | · | · | · | · | |
| Earnings Yield | -401.4% | -497.8% | · | -440.6% | -685.1% | -1174.4% | · | -246.5% | -101.3% | -42.7% | · | -17.0% | -6.1% | -1.9% | · | -2.6% |
财务报表 损益表、资产负债表、现金流量表 — 年度，近5年
损益表
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| 收入 | $642.0K | $2M | $1M | $375.0K | — |
| 营业利润率 % | -7860.0% | -2967.6% | -12448.0% | — | — |
| 净收入 | $-70M | $-60M | $-179M | $-166M | $-107M |
| 稀释后每股收益 (EPS) | $-5.73 | $-23.51 | $-98.33 | $-5.92 | $-4.05 |
资产负债表
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| 负债/股东权益比率 | -1.1 | -1.1 | -1.8 | — | — |
| 流动比率 | 0.8 | 1.7 | 2.6 | — | 14.2 |
| 速动比率 | 0.5 | 1.3 | 2.4 | — | 14.0 |
现金流
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| 自由现金流 | $-58M | — | $-155M | — | $-83M |
我的指标 您的个人关注列表 — 来自完整基本面的选定行
📊
选择对您重要的指标 — 点击上方完整基本面中任意行的 ➕。
您的选择已保存，并会跟随您浏览所有股票。
机构持有人 (13F) 50 家申报者 · $8.5M 总计 · 截至 2026年6月30日
在其季度SEC表格13F中报告持有此股票的机构。仅限多头头寸；单个申报人可能因单独的期权腿而出现两次。 大的抵消性看跌/看涨腿通常反映做市或对冲库存，而非方向性判断。
机构活动 — Q2 2026 与上一季度对比
| 新仓位 | 已退出持仓 | 增加 | 减少 | 净股数变动 |
|---|---|---|---|---|
| 14 (+9 与上一季度对比) | 3 (-5 与上一季度对比) | 7 (-2 与上一季度对比) | 9 (+3 与上一季度对比) | +725K |
与Q1 2026对比。 SEC 13F表格的提交截止日期是季度末后45天，外加少量延迟提交的缓冲期——在此窗口期内的季度将被跳过，优先显示最近一个已完整报告的季度对。
公司内部人士 19 位内幕人士 · 6 位高管 · 9 位董事
| 内部人士 | 角色 | 上次活动 | 持股数量 | 买入 12个月 | 卖出 12个月 | 净额 12个月 |
|---|---|---|---|---|---|---|
| Vimal Mehta | CEO and President | 2026年6月15日 M | 69817 | 0 | 1 | $-21167 |
| Richard I Steinhart | Chief Financial Officer | 2026年6月15日 M | 26335 | 0 | 1 | $-7393 |
| Javier Rodriguez | Chief Legal Officer, Senior Vice President and Corporate Secretary | 2026年6月15日 M | 26838 | 0 | 1 | $-7085 |
| Frank Yocca | Chief Scientific Officer | 2026年6月15日 M | 26210 | 0 | 1 | $-7393 |
| William P Kane Jr | Chief Commercial Officer | 2021年8月16日 A | — | 0 | 0 | $0 |
| Reina Benabou | Senior Vice President Clinical Research Neuroscience and Chief Development Officer | 2020年6月22日 A | — | 0 | 0 | $0 |
| June Bray | 董事 | 2026年1月9日 A | — | 0 | 0 | $0 |
| Sandeep Laumas | 董事 | 2026年1月9日 A | — | 0 | 0 | $0 |
| David J. Mack | 董事 | 2026年1月9日 A | 20317 | 0 | 0 | $0 |
| Michal Votruba | 董事 | 2026年1月9日 A | — | 0 | 0 | $0 |
| Rajiv Patni | 董事 | 2026年1月9日 A | — | 0 | 0 | $0 |
| Peter Mueller | 董事 | 2026年1月9日 A | 90000 | 0 | 0 | $0 |
| MILLER MICHAEL PATRICK | 董事 | 2026年1月9日 A | — | 0 | 0 | $0 |
| Krishnan Nandabalan | 董事 | 2023年4月6日 M | 0 | 0 | 0 | $0 |
| Susan E. Atkins | — | 2026年8月12日 A | — | 0 | 0 | $0 |
| Matthew T. Wiley | — | 2024年7月22日 A | 19011 | 0 | 0 | $0 |
| Vincent O'Neill | — | 2024年7月22日 A | 19957 | 0 | 0 | $0 |
| BioXcel Holdings, Inc. | — | 2021年6月25日 S | 8546750 | 0 | 0 | $0 |
| BioXcel Corp | — | 2021年6月25日 S | 8546750 | 0 | 0 | $0 |
来自SEC表格3/4/5申报的内部人士；净额=仅公开市场买卖
激进投资者及 5%+ 股东 2 持仓
提交了 SEC Schedule 13D 的投资者 — 持有超过 5% 的受益所有权，意图影响发行人（激进股东持股、董事会活动、并购）。每一行显示该申报人持仓的最新已知状态。
| 申报人 | 已申报 | 持股 | 状态 | 目的 | 申报 |
|---|---|---|---|---|---|
| BioXcel LLC, BioXcel Holdings, Inc., Vimal Mehta ×2 申报 | 2024年6月6日 | — | 初始申报 | — | SEC |
| DNCA FINANCE S.C.S ×4 申报 | 2020年3月6日 | — | 初始申报 | 被动投资 | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
ETF持仓 由 3 只交易所交易基金持有
权重仅反映直接股权持仓（N-PORT）；杠杆基金或基于衍生品的基金可能持有未显示的额外掉期敞口。